Success Metrics

Clinical Success Rate
55.6%

Based on 5 completed trials

Completion Rate
56%(5/9)
Active Trials
3(18%)
Results Posted
0%(0 trials)
Terminated
4(24%)

Phase Distribution

Ph not_applicable
7
41%
Ph phase_4
1
6%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 4Post-market surveillance
1(12.5%)
N/ANon-phased studies
7(87.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

55.6%

5 of 9 finished

Non-Completion Rate

44.4%

4 ended early

Currently Active

3

trials recruiting

Total Trials

17

all time

Status Distribution
Active(4)
Completed(5)
Terminated(4)
Other(4)

Detailed Status

Completed5
Terminated4
unknown4
Recruiting2
Not yet recruiting1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
17
Active
3
Success Rate
55.6%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (12.5%)
N/A7 (87.5%)

Trials by Status

terminated424%
recruiting212%
not_yet_recruiting16%
completed529%
active_not_recruiting16%
unknown424%

Recent Activity

3 active trials
Showing 5 of 17
not_yet_recruiting

Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)

NCT07500025
recruitingnot_applicable

Electrical Impedance Tomography for Assessment of Pulmonary Hypertension

NCT07453017
recruiting

Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension

NCT05566002
active_not_recruiting

Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure

NCT06023134
completednot_applicable

Fasting Versus Non-fasting on Outcomes and Satisfaction Prior to Cardiac Catheterization

NCT05851872
View all 17 trials

Clinical Trials (17)

Showing 17 of 17 trials
NCT07500025

Categorizing Patient Risk for Tricuspid Regurgitation (TR) Intervention With Admittance Pulmonary Artery Catheter System (APACS)

Not Yet Recruiting
NCT07453017Not Applicable

Electrical Impedance Tomography for Assessment of Pulmonary Hypertension

Recruiting
NCT05566002

Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension

Recruiting
NCT06023134

Clinical Characteristics and Outcomes of Patients With Pulmonary Hypertension Associated Right Heart Failure

Active Not Recruiting
NCT05851872Not Applicable

Fasting Versus Non-fasting on Outcomes and Satisfaction Prior to Cardiac Catheterization

Completed
NCT02594917

Genetic and Environmental Determinants That Control Metabolism in Pulmonary Hypertension

Completed
NCT04970953

Diastolic Exercise Stress Testing in Heart Failure

Terminated
NCT05672719

Hemodynamic Testing Strategies to Assess Pulmonary Hypertension in Heart Failure

Unknown
NCT05575557Not Applicable

Pulmonary Artery Pressure and Right Heart Evaluation for Patients Requiring Physiological Pacing Treatment

Unknown
NCT05665218

Comparison of Different Cardiac Output Measurement Methods in Patients Undergoing Right Heart Catheterization

Unknown
NCT05641675

Non-invasive Pulmonary Artery Prediction (ADOPTS)

Unknown
NCT04008550Not Applicable

Prognostic Impact of the Evolution of PAH 3 Months After TAVI (HTP-TAVI)

Terminated
NCT03089164

Postural Changes During Right Heart Catheterization

Terminated
NCT00075179Phase 4

Natrecor in Pulmonary Hypertension

Terminated
NCT02844036Not Applicable

Angioplasty of Distal Lesions for Carriers of Inoperable Post-embolic HTP

Completed
NCT01185730Not Applicable

Prospective Longitudinal Study of Patients With Idiopathic Pulmonary Arterial Hypertension, Family or Taking Anorectics

Completed
NCT01463514Not Applicable

Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension

Completed

All 17 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
17